This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Law Offices Of Ronald A. Marron, APLC Announces Preliminary Approval Of Class Action Settlement

SAN DIEGO, Feb. 20, 2013 /PRNewswire/ -- The following statement is being issued by the Law Offices of Ronald A. Marron, APLC pursuant to an order of the United States District Court for the Southern District of California:


A settlement has been reached in a proposed nationwide consumer class action lawsuit filed in the Southern District of California in San Diego entitled Nigh v. Humphreys Pharmacal, Incorporated and Dickinson Brands Inc. The plaintiff, Melissa Nigh, is represented by the Law Offices of Ronald A. Marron, APLC. Humphreys and Dickinson are represented by the law firms of Robinson & Cole LLP and Sheppard, Mullin, Richter & Hampton LLP.

The proposed settlement is subject to court approval and would provide for a fund of $1.4 million to which claims for rebates may be submitted for purchases since June 20, 2008 of any of Humphreys products labeled as homeopathic, including Arthritis Relief, Bedwetting Pellets, Cold Relief, Colic Pellets, Cough Control, Insomnia Relief, Simple Diarrhea, Simple Fever, Simple Nervous Conditions, Symptoms of Delayed Menses, Teething Pellets, and Teething Strips.

In the lawsuit, Ms. Nigh claims that Humphreys made misleading and confusing claims about the efficacy and ingredients of its homeopathic products. Ms. Nigh and Humphreys, through their counsel, engaged in lengthy negotiations, including formal mediation, to arrive at settlement terms that will address Ms. Nigh's claims. Those terms include adding disclaimers on the products' packaging that state: "These 'Uses' have not been evaluated by the Food and Drug Administration," and "'X' is a homeopathic dilution. For more information, see," which will refer customers to a designated Humphreys website for details. These disclaimers and other measures will be made a formal part of the settlement upon court approval. In addition, as a part of the settlement, Humphreys has agreed not to label its homeopathic products as "natural" or "all natural" if they contain synthetic ingredients, and not to claim "no animal ingredients" on products containing, for example, extremely small quantities of derivatives of cuttlefish and certain beetles as ingredients.

Humphreys and Ms. Nigh believe that these measures, including revision of Humphreys' Products' labels, will help consumers have necessary information about Humphreys' products and how homeopathic products work in general.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs